EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

α-Glucosidase Inhibitors from Two Mangrove-Derived Actinomycetes

Xuejun Lu, Manlai Zhang, Yixian Qiu, Xiuxiu Liu, Cancan Wang, Jianwei Chen iD, Huawei Zhang iD, Bin Wei, Yanlei Yu, Youmin Ying, Kui Hong, Hong Wang iD

Molecules · 2023

DOI: 10.3390/molecules28093822 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Xuejun Lu und 11 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Science & Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Techn…. Hauptthemen laut MEDLINE: Actinobacteria, Diabetes Mellitus, Type 2, Streptomyces. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Research and Development Program of Zhejiang Province, Natural Foundation of Zhejiang Province, National Key R&D Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

α-Glucosidase (AGS) inhibitors have been regarded as an ideal target for the management of type 2 diabetes mellitus (T2DM) since they can maintain an acceptable blood glucose level by delaying the digestion of carbohydrates and diminishing the absorption of monosaccharides. In the process of our endeavor in mining AGS inhibitors from natural sources, the culture broth of two mangrove-derived actinomycetes Streptomyces sp. WHUA03267 and Streptomyces sp. WHUA03072 exhibited an apparent inhibitory activity against AGS. A subsequent chemical investigation into the two extracts furnished 28 secondary metabolites that were identified by spectroscopic methods as two previously undescribed linear polyketides 1–2, four benzenoid ansamycins 3–6, fourteen cyclodipeptides 7–18, one prenylated indole derivative 19, two fusicoccane-type diterpenoids 20–21, two hydroxamate siderophore 22–23, and five others 24–28. Among all of the isolates, 11 and 24 were obtained from actinomycetes for the first time, while 20–21 had never been reported to occur in a marine-derived microorganism previously. In the in vitro AGS inhibitory assay, compounds 3, 8, 9, 11, 14, 16, and 17 exhibited potent to moderate activity with IC50 values ranging from 35.76 ± 0.40 to 164.5 ± 15.5 μM, as compared with acarbose (IC50 = 422.3 ± 8.4 μM). The AGS inhibitory activity of 3, 9, 14, 16, and 17 was reported for the first time. In particular, autolytimycin (3) represented the first ansamycin derivative reported to possess the AGS inhibitory activity. Kinetics analysis and molecular docking were performed to determine the inhibition types and binding modes of these inhibitors, respectively. In the MTT assay, 3, 8, 9, 11, 14, 16, and 17 exhibited no apparent cytotoxicity to the human normal hepatocyte (LO2) cells, suggesting satisfactory safety of these AGS inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ActinobacteriaDiabetes Mellitus, Type 2StreptomycesHumansGlycoside Hydrolase InhibitorsActinomycesMolecular Docking Simulationalpha-GlucosidasesMolecular Structure

Stichwörter der Autor:innen

Streptomycesalpha-glucosidasediabetes mellitusdiketopiperazinegeldanamycinmangrove microorganism

Substanzen

Glycoside Hydrolase Inhibitorsalpha-Glucosidases

Autor:innen und Institutionen

  • College of Pharmaceutical Science & Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, China.
  • Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, School of Pharmaceutical Sciences, Wuhan University, Wuhan 430072, China.
  • Key Laboratory of Marine Fishery Resources Exploitment and Utilization of Zhejiang Province, Zhejiang University of Technology, Hangzhou 310014, China.

ORCID-Profile: Jianwei Chen, Huawei Zhang, Hong Wang

Förderung

  • Key Research and Development Program of Zhejiang Province
  • Natural Foundation of Zhejiang Province
  • National Key R&D Program of China
  • High-level Talent Special Support Plan of Zhejiang Province
  • National Key R&D Program of China

Zitieren

APA

Lu, X., Zhang, M., Qiu, Y., Liu, X., Wang, C., Chen, J., Zhang, H., Wei, B., Yu, Y., Ying, Y., Hong, K., & Wang, H. (2023). α-Glucosidase Inhibitors from Two Mangrove-Derived Actinomycetes. Molecules. https://doi.org/10.3390/molecules28093822

Vancouver

Lu X, Zhang M, Qiu Y, Liu X, Wang C, Chen J, et al. α-Glucosidase Inhibitors from Two Mangrove-Derived Actinomycetes. Molecules. 2023. doi:10.3390/molecules28093822

BibTeX
@article{Lu2023,
  author = {Lu, Xuejun and Zhang, Manlai and Qiu, Yixian and Liu, Xiuxiu and Wang, Cancan and Chen, Jianwei and Zhang, Huawei and Wei, Bin and Yu, Yanlei and Ying, Youmin and Hong, Kui and Wang, Hong},
  title = {α-Glucosidase Inhibitors from Two Mangrove-Derived Actinomycetes},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28093822}
}
Kostenlos starten →